Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
Hereditary spastic paraplegia (HSP) describes a heterogeneous group of genetic neurodegenerative diseases characterised by progressive spasticity of the lower limbs. The pathogenic mechanism, associated clinical features, and imaging abnormalities vary substantially according to the affected gene and differentiating HSP from other genetic diseases associated with spasticity can be challenging. Next generation sequencing-based gene panels are now widely available but have limitations and a molecular diagnosis is not made in most suspected cases. Symptomatic management continues to evolve but with a greater understanding of the pathophysiological basis of individual HSP subtypes there are emerging opportunities to provide targeted molecular therapies and personalised medicine.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1474-4465
Volume Title
Publisher
Publisher DOI
Sponsorship
Medical Research Council (MR/L023784/1)